In this free webinar, Yokogawa’s own Arvonn Tully and InSphero’s Judi Wardwell-Swanson discuss practical considerations for transitioning high content imaging and analysis from 2D cell models to 3D spheroid disease models for drug discovery, and share lessons learned when setting up and conducting proof-of-concept studies designed to test the full potential for high resolution image-based analysis of 3D spheroid models. They will also provide an actionable, working checklist for researchers and core services groups that seek to employ these technologies in their work.
Date: 01/14/2021
Time: 11:00am - 12:00pm Eastern
Related Products & Solutions
-
Life Science
Yokogawa’s sensitivity and precision solutions enable rapid and accurate measurements, empowering groundbreaking research, accelerating drug discovery, and optimizing bio-production at scale.